Both in Pharmaceuticals
Ligand Pharmaceuticals vs Cogent Biosciences
Over the past year LGND returned +68.8% and COGT returned +100.1%; their daily moves had a correlation of 0.24.
LGND +68.8% COGT +100.1%Growth of $1, one year, split-adjusted
| Metric | LGND | COGT |
|---|---|---|
| Price | $322.75 | $31.02 |
| Market cap | $6.43B | $5.38B |
| Today | +1.71% | −2.94% |
| 1 month | +6.6% | −1.8% |
| 6 months | +41.9% | −15.3% |
| Year to date | +70.7% | −12.7% |
| 1 year | +74.9% | +93.9% |
| Revenue growth (YoY) | −31.8% | — |
| Gross margin | 83.7% | — |
| Net margin | −36.2% | — |
| P/E (TTM) | 125.0× | — |
| Price / sales | 25.3× | — |
| Net cash | -$653.3M | $568.8M |
| Dividend yield | — | — |
| Volatility (60d) | 28.0% | 39.5% |
| Short % of float | 13.3% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).